Our studies provided us with clues regarding the mechanisms underlying the effects of MIM-B and caveolin-1 in HCC and have also provided us with a theoretical basis for studying the clinical applicability of MIM-B/caveolin-1 interactions. This evidence concerns the gene CAV1 and hepatocellular carcinoma.